H5N1 influenza vaccine (PowderMed)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameH5N1 influenza vaccine (PowderMed)
Drug Alias NameH5N1 influenza vaccine (Pfizer)avian influenza vaccine (Pfizer)avian influenza vaccine (PowderMed)
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccine
Mechanisms of ActionInfluenza virus hemagglutinin glycoproteins modulators
TargetsInfluenza virus hemagglutinin glycoproteins
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPowdermed Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPowdermed Ltd
Active IndicationsN/A
Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A
Related LinksN/A